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Case ReportsUse of an automatic internal defibrillator to induce and maintain
ventricular fibrillation during left ventricular assist device
pump exchangeMatthew A. Levin, MD,a Anelechi C. Anyanwu, MD,b Charles A. Eggert, BSME,c and
Alexander J. C. Mittnacht, MD,a New York, NY, and St Paul, MinnAs the number of patients with left ventricular assist devices
(LVADs) increases,1,2 so will the number of surgical
interventions for device failure. In a recent review, 6.4%
of patients with a HeartMate II (Thoratec Corporation,
Pleasanton, Calif) required LVAD replacements for
various reasons.3 We report a case of LVAD replacement
during which the patient’s automatic implantable cardi-
overter defibrillator (AICD) was used to induce, maintain,
and eventually terminate ventricular fibrillation (VF) to
facilitate LVAD exchange.CASE REPORT
Written permission for publication was obtained from the
patient. A 77-year-old man with a history of ischemic car-
diomyopathy, St Jude Medical AICD (St Jude Medical
Inc, Austin, Tex) placement in 2007, and HeartMate II im-
plantation in 2011 presented for LVAD pump replacement
as a result of an internal fracture of the power supply cable,
causing a short circuit.
General anesthesia was induced and maintained in a stan-
dard fashion. Cardiopulmonary bypass (CPB) was insti-
tuted via right axillary arterial and venous, as well as
femoral venous cannulation. A minimally invasive left sub-
costal incision was chosen to avoid the morbidity of reoper-
ative sternotomy. Because the patient had mild aortic
regurgitation, disarticulation and connection of the LVAD
could result in a bloody operative field and risk of air ejec-
tion once the new device was connected. Before surgery, the
patient was in a normal paced rhythm. On institution of
CPB, the LVAD flow was reduced. Through the subcostal
incision, the inflow and outflow limbs of the ventricular
assist device were isolated, the outflow graft was clamped,
and the LVAD flow was discontinued. Antitachycardia ther-
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ulation with a pacing cycle length of 60 milliseconds. The
LVAD pump was then disarticulated from the inflow and
outflow limbs. Subsequently, the patient remained in sus-
tained VF and we replaced the LVAD pump. The pump
was deaired through a needle in the outflow graft, just distal
to its connection to the pump in the subcostal incision. On
confirmation of adequate deairing via transesophageal
echocardiography, defibrillation was attempted with exter-
nally placed defibrillator pads, but was unsuccessful. Anti-
tachycardia therapy was reenabled on the device, selecting a
single VF zone at a low rate and low number of intervals
with all shocks set to maximum outputs. The AICD success-
fully terminated VF, and the patient resumed and main-
tained a stable paced rhythm. The patient was in VF for a
total of 21 minutes. The patient was weaned off CPB un-
eventfully with the new LVAD pump in situ. The remainder
of the procedure and hospital stay was uneventful and the
patient was discharged home after 11 days. Analysis of
the explanted pump confirmed internal driveline fracture.DISCUSSION
There are significant risks associated with resternotomy
and LVAD exchange. For isolated pump exchange, the sub-
costal route may be preferable in selected patients. One
concern with this approach, however, has been difficulty in
deairing and systemic air ejection during pump exchange.
As the ascending aorta cannot be accessed, there is no means
of capturing air ejected into the aorta. To address this prob-
lem, Woo and Acker4 have described placement of a venting
pigtail catheter via the femoral artery into the aortic root to
capture any air that is ejected. Typically, the procedure is
done with the heart beating, such that the left ventricle can
eject any residual air into the aorta immediately after the de-
vice is connected (as this closes off the apical route for ejec-
tion). VFmay allowmore controlledmanagement of air, as it
allows passive deairing of the ventricle via a needle in the
outflow graft, such that the heart does not eject until deairing
is accomplished. However, most cases can likely be reason-
ably deaired without fibrillation of the heart because maneu-
vers such as connection of cardiotomy suction to the outflow
cannula, steep Trendelenburg positioning, carbon dioxide
insufflation, and needling of outflow graft should eliminate
most air. However, air entrainment can occasionally berdiovascular Surgery c Volume 147, Number 3 e17
Case Reportstroublesome and fibrillationmay afford an additional layer of
protection and allow more effective deairing in some cases.
Additional benefits from fibrillating the heart during pump
exchange are reduced blood loss from the apical inflow site
during pump exchange and decreased risk of blood contact
contamination of the operating team from an ejecting left
ventricle. Because most patients with an LVAD also have
an AICD in situ, we suggest that the method described here
is a simplemeans to induce,maintain, and reverse fibrillation.
Although dissecting out the base of the right ventricle to atta-
ch a fibrillator lead is also possible, this adds another layer of
complexity to the surgery with increased risk of bleeding and
injury to the heart, and risks unanticipated cardiac ejection if
wires are displaced and the heart beats spontaneously. By us-
ing theAICD to fibrillate, wewere able to keep the procedure
almost entirely within the LVAD pocket, making it truly
minimally invasive. Furthermore, as seen in our case, defi-
brillation by external pads may be difficult.From the Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical
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e18 The Journal of Thoracic and Cardiovascular SurgThe potential applications of this approach are not
limited to LVAD device exchange, but could be extended
to other minimal access cardiac surgical procedures in pa-
tients who have AICDs. The approach may be useful in
such procedures, particularly where access to the heart is
limited, or where there is a desire to avoid aortic clamping,
such as mitral valve repair via thoracotomy in a patient with
previous coronary bypass grafts and depressed ventricular
function.
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intravascular deairing techniques. Ann Thorac Surg. 2011;91:306-7.Cardiac hemangioma at the apex of the right ventricle: A case report
and literature reviewWen-Jian Jiang, MD, Jin-Hua Li, MD, Jiang Dai, MD, and Yong-Qiang Lai, MD, Beijing, ChinaPrimary tumors and cysts of the heart and pericardium
are rare, and only 2.8% of these tumors are cardiac
hemangiomas.1 Ventricular hemangiomas are extremely
uncommon. We report one of these unusual cases and
discuss others in the literature.
CLINICAL SUMMARY
A 49-year-old man without symptoms was admitted to
our hospital. A mass between the right ventricle (RV) and
the pericardium was demonstrated on his chest computed
tomography (Figure 1, A). Transthoracic echocardiography
showed the mass to be located at the apex of the RV, and
there was no hemodynamic abnormality or RVoutflow tract
obstruction.The mass adjacent to the RV had a clear border with the
normal myocardium (Figure 1, B). It was totally excised
under cardiopulmonary bypass. A patch of autologous
pericardium covered with Dacron polyester fabric was
used for the reconstruction of the RV (Figure 1, C). This
patient recovered uneventfully, with no evidence of recur-
rence after 6 months of follow-up. The size of the mass
was 6.83 5.03 2.6 cm (Figure 1, D). Histologic diagnosis
was hemangioma (Figure 1, E).DISCUSSION
Primary tumors and cysts of the heart and pericardium
are rare, and only 2.8% of these tumors are cardiac
hemangiomas.1 Hemangiomas of the heart affect all ages
and may occur anywhere within the heart,2 but ventricular
hemangiomas are extremely uncommon. In 45 reviewed
cases of cardiac hemangioma, only 11 were located in the
RV.3 Cardiac hemangiomas are vascular tumors composed
of capillaries or cavernous vascular channels, and most
are benign.4 Surgery is the first choice of therapy in all pa-
tients with cardiac tumors.5
To date, 30 cases of hemangiomas located in the RV
(including that reported here) have been reported in the
literature. Table 1 shows the summary of preoperative
data and lists the surgical procedures in these cases. Theery c March 2014
